
1. rev inst med trop sao paulo. 2002 jan-feb;44(1):13-6.

nutritional status relation efficacy rhesus-human reassortant,
tetravalent rotavirus vaccine (rrv-tv) infants belém, pará state, brazil.

linhares ac(1), carmo kb, oliveira kk, oliveira cs, freitas rb, bellesi n,
monteiro ta, gabbay yb, mascarenhas jd.

author information: 
(1)seção de virologia, instituto evandro chagas, fundação nacional de saúde,
ministério da saúde, belém, pará, brasil. alexandrelinhares@iec.pa.gov.br

the rhesus-human reassortant, tetravalent rotavirus vaccine (rrv-tv) licensed
for routine use united states america recently withdrawn
from market possible association intussusception an
adverse event. protective efficacy 3 doses rrv-tv, lower-titer
(4 x 10(4) pfu/dose) formulation, evaluated according nutritional
status infants participated phase iii trial belém, northern
brazil. moderate protection conferred rrv-tv related weight-for-age
z-scores (waz) greater -1 only, rates 38% (p = 0.04) 40% (p =
0.04) all- and- pure rotavirus diarrhoeal cases, respectively. addition,
there trend greater efficacy (43%, p = 0.05) among infants reaching 
height-for-age z-score (haz) > -1. taking waz, haz weight-for-height
z-score (whz) indices </= -1 together, significant protection (p >
0.05) placebo vaccine groups compared. significant
difference rates mixed pure rotavirus diarrhoeal cases compared 
relation haz, waz weight-for-height z-score (whz) indices. although low 
number malnourished infants could identified present study, data
show evidence malnutrition may interfere efficacy rotavirus
vaccines developing countries.

doi: 10.1590/s0036-46652002000100003 
pmid: 11896407  [indexed medline]

